Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof

C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof

US Patent 8022174 · Granted Sep 20, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered γδ T-cells2025
Methods for selective expansion of gamma delta t-cell populations and compositio2025
Methods for selective expansion of delta-3 gamma delta T-cell populations and co2025
Borylated amino acid compositions for use in boron neutron capture therapy and m2024
Borylated amino acid compositions for use in boron neutron capture therapy and m2023
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins2023
Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses t2022
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2022
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2022
Methods for selective expansion of γδ T-cell populations and compositions thereo2022
Engineered γδ T-cells2021
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins2021